Large caps most expensive in pharmaceutical sector

Within the pharmaceutical sector, we see a low diversification of the 12-months returns. Since February last year the sector is around 2 percent higher. Among the winners we find Amarinoration, BioArctic AB and ProQR Therapeutics NV. Relatively big losses were for Faron Pharmaceuticals Oy, Cytori Therapeutics and Sunesis Pharmaceuticals.

Core figures pharmaceutical sector

The winners in this sector are the megacaps, while smallcaps are mostly among the less performers.

Lowest PE-ratios pharmaceutical sector

Regarding the price/earnings-ratios we see a diversified palette. The large caps are with the price/earnings-ratio of 21 the most expensive. The smallcaps are the cheapest and trade at -6 times the earnings per share. Oxford BioMedica, Shield Therapeutics and Abcam are the stocks with the highest ratios. Stocks with the lowest ratios are Mallinckrodt, Endo International and Assertio Therapeutics.

Highest dividend yields pharmaceutical sector

The sector's average dividend yield is with 0,7 percent relatively limited. Stocks now high dividend yields now are Biotoscana Investments SA, AbbVie and Orion.

This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.